Natural history and treatment of chronic delta hepatitis C Yurdaydın, R Idilman, H Bozkaya, AM Bozdayi Journal of viral hepatitis 17 (11), 749-756, 2010 | 208 | 2010 |
Cytotoxic CD4+ T cells in viral hepatitis N Aslan, C Yurdaydin, J Wiegand, T Greten, A Ciner, MF Meyer, H Heiken, ... Journal of viral hepatitis 13 (8), 505-514, 2006 | 195 | 2006 |
Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients AM Bozdayı, N Aslan, G Bozdayı, AR Türkyılmaz, T Sengezer, U Wend, ... Archives of virology 149, 2115-2129, 2004 | 191 | 2004 |
Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review M Toy, FO Önder, T Wörmann, AM Bozdayi, SW Schalm, GJ Borsboom, ... BMC infectious diseases 11, 1-12, 2011 | 189 | 2011 |
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon C Yurdaydın, H Bozkaya, FO Önder, H Şentürk, H Karaaslan, M Akdoğan, ... Journal of Viral Hepatitis 15 (4), 314-321, 2008 | 171 | 2008 |
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: the LOWR HDV‐1 study C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, E Karatayli, ... Hepatology 67 (4), 1224-1236, 2018 | 154 | 2018 |
Famciclovir treatment of chronic delta hepatitis C Yurdaydin, H Bozkaya, S Gürel, HL Tillmann, N Aslan, A Okçu-Heper, ... Journal of hepatology 37 (2), 266-271, 2002 | 143 | 2002 |
Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. H Bozkaya, M Bozdayi, R Türkyilmaz, M Sarioglu, H Cetinkaya, K Cinar, ... Hepato-gastroenterology 47 (36), 1675-1679, 2000 | 116 | 2000 |
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine AM Bozdayi, Ö Uzunalimoğlu, AR Türkyilmaz, N Aslan, O Sezgin, T Sahin, ... Journal of viral hepatitis 10 (4), 256-265, 2003 | 112 | 2003 |
Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies R Idilman, M Arat, E Soydan, M Törüner, I Soykan, H Akbulut, Ö Arslan, ... Journal of viral hepatitis 11 (2), 141-147, 2004 | 110 | 2004 |
Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection G Bozdayi, AR Türkyilmaz, R Idilman, E Karatayli, S Rota, C Yurdaydin, ... Journal of medical virology 76 (4), 476-481, 2005 | 109 | 2005 |
Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis O Erkan, AM Bozdayi, S Disibeyaz, D Oguz, M Ozcan, K Bahar, ... European journal of gastroenterology & hepatology 17 (3), 339-343, 2005 | 106 | 2005 |
Effect of Turkish propolis extracts on proteome of prostate cancer cell line Y Barlak, O Değer, M Çolak, SC Karataylı, AM Bozdayı, F Yücesan Proteome science 9, 1-11, 2011 | 104 | 2011 |
Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, G Kabaçam, ... The Journal of infectious diseases 217 (8), 1184-1192, 2018 | 99 | 2018 |
A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis C Yurdaydın, H Bozkaya, H Karaaslan, FO Önder, ÖE Erkan, K Yalçın, ... Journal of viral hepatitis 14 (11), 812-816, 2007 | 77 | 2007 |
HB eAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome B Heidrich, B C. Serrano, R Idilman, G Kabaçam, B Bremer, R Raupach, ... Liver International 32 (9), 1415-1425, 2012 | 75 | 2012 |
NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease SC Özen, Ü Daǧlı, MY Kiliç, M Törüner, Y Çelik, M Özkan, I Soykan, ... Journal of gastroenterology 41, 304-310, 2006 | 75 | 2006 |
Clarithromycin resistance prevalence and Icea gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia H Baglan Peren, B Gulendam, O Muhip, A Kamruddin, BA Mithat, O Ali Journal of microbiology 44 (4), 409-416, 2006 | 71 | 2006 |
Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels AM Bozdayı, H Bozkaya, AR Türkyılmaz, M Sarýodlu, H Çetinkaya, ... Journal of clinical virology 21 (1), 91-101, 2001 | 66 | 2001 |
Entecavir treatment of chronic hepatitis D G Kabaçam, FO Önder, M Yakut, G Seven, SC Karatayli, E Karatayli, ... Clinical infectious diseases 55 (5), 645-650, 2012 | 63 | 2012 |